ImmuCell Corporation Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
ImmuCell Corporation (ICCC) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 2.50% for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-05-14
- ImmuCell Corporation fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2018-03-31 was 2.50%, a 31.58% increase year-over-year.
- ImmuCell Corporation fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2017-09-30 was 1.90%.
- ImmuCell Corporation fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2017-06-30 was 1.80%.
- ImmuCell Corporation fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 1.90%.
- ImmuCell Corporation fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2016 was 1.20%, a 40.00% decline from fiscal 2015.
- ImmuCell Corporation fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2015 was 2.00%.
- ImmuCell Corporation fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 1.60%, a 64.95% increase from fiscal 2012.
- ImmuCell Corporation fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 0.97%, a 11.82% decline from fiscal 2011.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | 2.50% 10-Q · filed 2018-05-14 | |||
| 2017-12-31 | 1.90% 10-Q · filed 2018-05-14 | |||
| 2017-09-30 | 1.90% 10-Q · filed 2017-11-13 | 1.90% 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | 1.80% 10-Q · filed 2017-08-14 | 1.90% 10-Q · filed 2017-08-14 | ||
| 2017-03-31 | 1.90% 10-Q · filed 2017-05-11 | |||
| 2016-12-31 | 1.20% 10-K · filed 2018-03-29 | |||
| 2016-09-30 | 1.20% 10-Q · filed 2016-11-10 | |||
| 2016-06-30 | 2.00% 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | 2.00% 10-K · filed 2017-03-30 | |||
| 2014-12-31 | 2.00% 10-Q · filed 2016-08-11 | |||
| 2013-12-31 | 1.60% 10-K · filed 2015-03-26 | |||
| 2012-12-31 | 0.97% 10-K · filed 2015-03-26 | |||
| 2011-12-31 | 1.10% 10-K · filed 2014-03-26 | |||
| 2010-12-31 | 2.40% 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |